Do tirofiban and ReoPro give similar efficacy trial. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization for TARGET Investigators - Topol,E.J.; Moliterno,D.J.; Herrmann,H.C. (N Engl J Med, 2001)